Business
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products.
About this update from Cbd Life Sciences Inc.
[{"type":"text","content":"Leveraging Alibaba's 1.28 billion annual active consumers and $3 trillion in gross merchandise volume to accelerate growth and global market penetration.SCOTTSDALE, AZ / ACCESSWIRE / October 10, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), a trailblazer in the CBD industry, proudly announces a bold new step in its expansion strategy by targeting Alibaba, the world's largest retail and e-commerce platform. With an eye on global dominance, CBDL is set to offer its top-selling CBD products to Alibaba's vast wholesale marketplace, unlocking access to over 1.28 billion annual active consumers and an astounding $3 trillion in gross merchandise volume (GMV). This move marks a significant milestone in CBD Life Sciences' rapid ascent and positions the company for exponential revenue growth and global market penetration. "Our entrance into Alibaba is more than just an expansion-it's a game-changer," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "Alibaba's platform opens up access to markets we've only just begun to explore, and this leap forward will not only drive our revenue to new heights but will strengthen our relationship with valued shareholders, who are the backbone of our success."Massive Opportunity: Alibaba's Wholesale PowerhouseAlibaba is the world's top e-commerce platform, facilitating over $172 billion in cross-border commerce annually. For CBD Life Sciences, this presents a massive opportunity to capitalize on the growing demand for high-quality CBD products in regions where CBD is rapidly gaining popularity. CBDL's flagship products-ranging from nano CBD coffee creamers and pain relief creams-will now be available to wholesalers across Asia, Europe, and beyond.By tapping into Alibaba's extensive network of buyers, CBD Life Sciences is positioning itself as a leading supplier of CBD products to retailers around the globe. This expansion is expected to amplify both domestic and international sales, contributing to the already 1405.46% revenue increase the company has experienced since February 2024.Unstoppable Growth and Shareholder ConfidenceSince early 2024, CBD Life Sciences has maintained an impressive upward trajectory, breaking records quarter after quarter. Shareholders have witnessed the company's evolution from a pioneering CBD startup to an industry leader with a diverse pro...